About EmeraMed : EmeraMed

EmeraMed: who we are…

EmeraMed Limited is a privately held limited liability company (corporation) organized and headquartered in the Republic of Ireland. The Company currently operates in Ireland, Sweden and the United States. The Company’s owner group is primarily composed of physicians, dentists, and patients with personal experience of the product from when it was previously sold as a dietary supplement. If you are interested in learning more about the Company, please use our Contact page to request additional information.

This information is provided for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security in any jurisdiction.

Emeramide: A unique chelator

Emeramide is a lipophilic, di-thiol antioxidant, anti-viral, and metal chelator. Orphan Drug Designations were received for the treatment of mercury toxicity in the EU and US. Pre-clinical safety studies, a Phase I trial, and four Phase II trials have been performed targeting multiple indications. The Company is working to obtain marketing authorization in the US, the EU and in South America for the treatment of mercury toxicity in humans, and in the US and the EU for animals.

International Non-Proprietary Name (INN): Emeramide
Molecule: N,N’-bis(2-mercaptoethyl)isophthalamide (NBMI)

Our research and development efforts are committed to improving the health and well being of people and animals around the world by applying sound principles of medicine and science and working collaboratively with internationally renowned researchers and university centers.

Meet Our Team

Boyd Haley, PhDChief Scientist & CEO

Over the last two decades Dr. Haley has lectured throughout the world and testified before Congressional oversight committees and the Institute of Medicine regarding various aspects of mercury toxicity and neurological diseases.
READ MORE

Ragnar KlingbergBoard Member

Mr Klingberg has a background in management consulting and as an entrepreneur. He has been with EmeraMed since 2011.
READ MORE

Kathryn WachsmanBoard Secretary

Kathryn Wachsman is a practicing attorney with over three decades of experience in legal advocacy including litigation, mediation, negotiation, and legal analysis. She possesses extensive business experience…
READ MORE

Paul Reicherter, MDBoard Member

Paul Reicherter MD, is a graduate of Baker University in Kansas where he was a scholar athlete and Magna Cum Laude graduate. He earned his medical degree at the University of Kansas Medical Center where he graduated with highest honors and was inducted into the Alpha Omega Alpha Honor Medical Society.
READ MORE

Discover The Future of Health

We are committed to improving health by way of Emeramide, our unique antioxidant, which has several mechanisms of action that assist the body to fight viral infections and remove heavy metals.